| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/13/2009 | WO2009099222A1 Process and apparatus for production of composition having high polyphenol content |
| 08/13/2009 | WO2009099221A1 Production method and production device for composition having high content of theobromine |
| 08/13/2009 | WO2009099220A1 Process and apparatus for production of composition having high polyphenol content |
| 08/13/2009 | WO2009099195A1 Skin whitening agent and external preparation for the skin |
| 08/13/2009 | WO2009099194A1 Skin whitening agent and external preparation for the skin |
| 08/13/2009 | WO2009099193A1 Skin whitening agent and external preparation for the skin |
| 08/13/2009 | WO2009099192A1 Skin whitening agent and external preparation for the skin |
| 08/13/2009 | WO2009099177A1 Amino imidazole derivative |
| 08/13/2009 | WO2009099174A1 Therapeutic agent or preventive agent for inflammatory bowel disease containing amino alcohol derivative as active ingredient |
| 08/13/2009 | WO2009099172A1 Pharmaceutical product |
| 08/13/2009 | WO2009099171A1 Pharmaceutical product |
| 08/13/2009 | WO2009099163A1 Pyrrolopyrimidin derivative for use as pi3k inhibitor, and use thereof |
| 08/13/2009 | WO2009099132A1 Method for improving storage stability of glutathione |
| 08/13/2009 | WO2009099087A1 Benzylpiperizine compound |
| 08/13/2009 | WO2009099086A1 3-substituted sulfonyl piperazine derivative |
| 08/13/2009 | WO2009099080A1 Novel phenylpyrrole derivative |
| 08/13/2009 | WO2009098901A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | WO2009098716A2 Stabilized aqueous formulation containing paracetamol |
| 08/13/2009 | WO2009098710A1 Formocresol gel |
| 08/13/2009 | WO2009098700A1 Siva 3, its preparation and use |
| 08/13/2009 | WO2009098697A1 Modafinil and sildenafil dosage forms |
| 08/13/2009 | WO2009098690A2 Novel fer -like protein, pharmaceutical compositions containing it and method for its use |
| 08/13/2009 | WO2009098663A1 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
| 08/13/2009 | WO2009098661A1 Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability |
| 08/13/2009 | WO2009098649A1 Immunosuppressive macrolide powder for oral suspension |
| 08/13/2009 | WO2009098576A1 Pyridinyl amides for the treatment of cns and metabolic disorders |
| 08/13/2009 | WO2009098515A1 Novel process for the preparation of vorinostat |
| 08/13/2009 | WO2009098501A1 Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid |
| 08/13/2009 | WO2009098490A1 Antimicrobial agents for the treatment of campylobacter species in the crop of a bird |
| 08/13/2009 | WO2009098476A1 Topical antimicrobial compositions |
| 08/13/2009 | WO2009098458A2 Difluorobiphenylamide derivatives for the treatment of ocular hypertension |
| 08/13/2009 | WO2009098455A1 2- (9h-xanthen-9-yl) -oxazol derivatives as m3 muscarinic receptor antagonists for the treatment of asthma and chronic obstructive lung disease |
| 08/13/2009 | WO2009098453A1 Azonia bicycloalkanes as m3 muscarinic acetylcholin receptor antagonists |
| 08/13/2009 | WO2009098448A1 Compounds |
| 08/13/2009 | WO2009098404A2 Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof |
| 08/13/2009 | WO2009098400A1 Compound of the disaccharide type composition comprising and method for producing such a compound |
| 08/13/2009 | WO2009098369A1 Antimitotic compounds derived from vinca alkaloids, preparation thereof and therapeutic use thereof |
| 08/13/2009 | WO2009098320A2 Macrolides for treating diseases mediated through pde inhibition |
| 08/13/2009 | WO2009098283A1 (dihydro)pyrrolo[2,1-a]isoquinolines |
| 08/13/2009 | WO2009098282A1 Low molecular weight 2,5-disubstituted thiophene derivatives and use thereof in therapy |
| 08/13/2009 | WO2009098279A1 Protective effect of high dose folate on mycardial ischemia |
| 08/13/2009 | WO2009098276A1 Substituted piperidines as renin inhibitors |
| 08/13/2009 | WO2009098275A1 Substituted piperidines as renin inhibitors |
| 08/13/2009 | WO2009098236A1 Pyrrolo [2, 3-d] pyridines and use thereof as tyrosine kinase inhibitors |
| 08/13/2009 | WO2009098209A1 Novel 9-aza-bicyclo[3.3.1]non-3-yloxy chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/13/2009 | WO2009098208A1 Novel phenylethynyl derivatives of 8-aza-bicyclo[3.2.1]octane and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/13/2009 | WO2009098206A1 Molecules comprising a bis(heteroaryl)maleimide backbone, and use thereof in the inhibition of dde/ddd enzymes |
| 08/13/2009 | WO2009098195A1 Oral pharmaceutical formulations containing gliclazide |
| 08/13/2009 | WO2009098193A1 The hemi-fumarate salt of a 1,3,4-thiadiazolyl derivative as modulator of the sphingosine 1-phosphate receptor |
| 08/13/2009 | WO2009098186A1 Organic compounds |
| 08/13/2009 | WO2009098169A1 Orally disintegrating tablets with speckled appearance |
| 08/13/2009 | WO2009098144A1 Novel pyridinones and pyridazinones |
| 08/13/2009 | WO2009098142A1 Prasugrel salts with improved properties |
| 08/13/2009 | WO2009098136A1 Novel imidazolinylmethyl aryl sulfonamides |
| 08/13/2009 | WO2009098135A1 Novel imidazolinylmethyl aryl sulfonamides |
| 08/13/2009 | WO2009098134A1 N-[3-bromo-2-chloro-4-(4, 5-dihydro-1h-imidazol-2-ylmethyl)-phenyl] -methanesulfoamide as alpha-1 a adrenergic partial agonist for the treatment of incontinence |
| 08/13/2009 | WO2009098133A1 Novel imidazolinylmethyl aryl sulfonamides |
| 08/13/2009 | WO2009098127A1 Biocompatible injectable products with zinc and/or zinc-form saccharide-salt release, and uses thereof |
| 08/13/2009 | WO2009098116A1 9-substituted camptothecin derivatives as antitumor compounds |
| 08/13/2009 | WO2009098113A1 Nitric oxide donor compounds |
| 08/13/2009 | WO2009098082A2 Antiinfective and antitumoral compounds isolated from tropical lianas |
| 08/13/2009 | WO2009098061A1 Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production |
| 08/13/2009 | WO2009098051A1 Aryl sulfonamides as effective analgesics |
| 08/13/2009 | WO2009098008A2 3-(2-dimethylaminomethyl-cyclohexyl)-phenol against polyneuropathic pain |
| 08/13/2009 | WO2009098000A1 Heterocyclically-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
| 08/13/2009 | WO2009097999A1 Aryl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
| 08/13/2009 | WO2009097998A1 Arylchalcogeno-arylalkyl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
| 08/13/2009 | WO2009097996A1 Use of substituted phenylimidazolidines for producing medicaments for treating metabolic syndrome |
| 08/13/2009 | WO2009097995A1 Novel phenyl-substituted imidazolidines, method for the production thereof, medicaments containing said compounds and use thereof |
| 08/13/2009 | WO2009097991A1 Substituted furans and use thereof |
| 08/13/2009 | WO2009097973A2 Imidazopyridazines as par1 inhibitors, production thereof, and use thereof as medicaments |
| 08/13/2009 | WO2009097972A1 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | WO2009097971A1 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | WO2009097970A1 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | WO2009097893A1 Methods for the treatment of cardiac disease associated to myocardial fibrosis using an inhibitor of pcp |
| 08/13/2009 | WO2009097874A1 Amino acid formulations comprising cysteine, methionine and/or serine for the prevention of paracetamol-induced liver damage |
| 08/13/2009 | WO2009097774A1 The use of aryl piperazine derivatives in manufacturing medicants for treating pain |
| 08/13/2009 | WO2009097735A1 Use of compounds extracted from momordica charantia l. in the manufacture of medicaments for prevention and treatment of diabetes and obesity |
| 08/13/2009 | WO2009097709A1 Pyrazolopyrimidinone-containing phenyl guanidine derivatives, pharmaceutical compositions containing them, process for their preparation and their use |
| 08/13/2009 | WO2009097695A1 Arylmethylidene heterocycles as novel analgesics |
| 08/13/2009 | WO2009097691A1 USE OF P27kip1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE |
| 08/13/2009 | WO2009097688A1 Compositions and methods for alleviating depression or improving cognition |
| 08/13/2009 | WO2009097682A1 Anti-influenza compounds |
| 08/13/2009 | WO2009097670A1 Combination of immunomodulator and anti-pathogenic agent |
| 08/13/2009 | WO2009097651A1 Methods and compositions for treating inflammatory bowel disease |
| 08/13/2009 | WO2009078588A3 Composition for prevention and treatment of cancer containing pyrimidine derivatives inhibiting activity of protein phosphatases or pharmaceutically acceptable salts thereof as an active ingredient |
| 08/13/2009 | WO2009077485A3 1(2)h-tetrazol-5-yl-phenyl-oxazolidinones as antibacterial agents |
| 08/13/2009 | WO2009076321A3 Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides |
| 08/13/2009 | WO2009075857A3 Glycine transporter-1 inhibitors |
| 08/13/2009 | WO2009074575A3 Organic compounds |
| 08/13/2009 | WO2009073517A3 Intravesical compositions with valrubicin for the treatment of bladder cancer |
| 08/13/2009 | WO2009073508A3 Polysaccharide gel compositions and methods for sustained delivery of drugs |
| 08/13/2009 | WO2009073460A3 Inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 for ocular neuroprotection |
| 08/13/2009 | WO2009072132A3 Beta glycolipids for the treatment of calcification related degenerative disorders |
| 08/13/2009 | WO2009070684A3 Hemostatic material |
| 08/13/2009 | WO2009068253A3 Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-yl ester |
| 08/13/2009 | WO2009067607A3 Combinations of pde4 inhibitors and antipsychotics for the treatment of psychotic disorders |
| 08/13/2009 | WO2009064458A3 Compositions for the treatment of inflammation of the gastrointestinal tract |
| 08/13/2009 | WO2009064457A3 Corticosteroid compositions |
| 08/13/2009 | WO2009064417A3 Compositions for the treatment of gastrointestinal inflammation |